Border Force intercepts counterfeit semaglutide


Regulator issues warning after a shipment of substandard semaglutide was seized at the border  Health practitioners and patients are being urged to be aware of the potential risks posed by counterfeit weight loss products purchased online.   The Therapeutic Goods Administration (TGA) announced that “examples of substandard Fitaro semaglutide pre-filled syringes have been stopped at

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Panadol ‘most trusted’ for pain
Next ‘Chronically underfunded’: Calls to future-proof workforce